REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06444880 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2028-07-31 → 2027-07-31 3. enrollment: 40 → 15 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06444880 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2028-07-31 → 2027-07-31 3. enrollment: 40 → 15 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical